| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Che-Ming Jack Hu | |
| Liangfang Zhang | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| drug metabolism | Q1124842 | ||
| P304 | page(s) | 836-841 | |
| P577 | publication date | 2009-10-01 | |
| P1433 | published in | Current Drug Metabolism | Q15724618 |
| P1476 | title | Therapeutic nanoparticles to combat cancer drug resistance | |
| P478 | volume | 10 |
| Q43773969 | Acidity-promoted cellular uptake and drug release mediated by amine-functionalized block polycarbonates prepared via one-shot ring-opening copolymerization |
| Q39513734 | Advanced materials for co-delivery of drugs and genes in cancer therapy |
| Q93184904 | Advances in nanocarriers as drug delivery systems in Chagas disease |
| Q34714270 | An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistance |
| Q37031597 | Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review |
| Q37002153 | Applications of nanoparticle drug delivery systems for the reversal of multidrug resistance in cancer. |
| Q35007929 | Augmented cytotoxicity of hydroxycamptothecin-loaded nanoparticles in lung and colon cancer cells by chemosensitizing pharmaceutical excipients |
| Q34194191 | Bioengineering strategies for designing targeted cancer therapies |
| Q34157584 | Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives |
| Q35991005 | Codelivery of SH-aspirin and curcumin by mPEG-PLGA nanoparticles enhanced antitumor activity by inducing mitochondrial apoptosis |
| Q36657133 | Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo |
| Q38523659 | Combinatorial nanomedicines for colon cancer therapy |
| Q34726981 | Delivering nanomedicine to solid tumors |
| Q35571539 | Effective photothermal chemotherapy with docetaxel-loaded gold nanospheres in advanced prostate cancer |
| Q28073956 | Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective. |
| Q39194505 | Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release. |
| Q28817211 | Evaluation of β-cyclodextrin-modified gemini surfactant-based delivery systems in melanoma models |
| Q28082374 | Exploring the tumor microenvironment with nanoparticles |
| Q91988882 | Functional biomimetic nanoparticles for drug delivery and theranostic applications in cancer treatment |
| Q38095361 | Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance. |
| Q28488394 | Functionalized graphene oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitro |
| Q39459376 | Herceptin-directed nanoparticles activated by an alternating magnetic field selectively kill HER-2 positive human breast cells in vitro via hyperthermia |
| Q27300853 | Improving Nanoparticle Penetration in Tumors by Vascular Disruption with Acoustic Droplet Vaporization |
| Q91950939 | Inhibition of the adenosinergic pathway: the indispensable part of oncological therapy in the future |
| Q92588191 | Microfluidic device for the analysis of MDR cancerous cell-derived exosomes' response to nanotherapy |
| Q90348651 | Multifunctional nanomedicines for targeting epidermal growth factor receptor in colorectal cancer |
| Q36307634 | Multistage vector (MSV) therapeutics |
| Q38856533 | Nano-based strategies to overcome p-glycoprotein-mediated drug resistance. |
| Q27500424 | Nanomaterials for reversion of multidrug resistance in cancer: a new hope for an old idea? |
| Q40059157 | Nanoparticle Attachment to Erythrocyte Via the Glycophorin A Targeted ERY1 Ligand Enhances Binding without Impacting Cellular Function |
| Q38250517 | Nanoparticulate carriers: an emerging tool for breast cancer therapy |
| Q38183852 | Nanoscale particulate systems for multidrug delivery: towards improved combination chemotherapy |
| Q33909084 | Nanoways to overcome docetaxel resistance in prostate cancer |
| Q36161060 | PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells |
| Q38779853 | PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer |
| Q38166550 | Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies |
| Q57483726 | Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor |
| Q59801893 | Regulation of in vivo behavior of TAT-modified liposome by associated protein corona and avidity to tumor cells |
| Q38968952 | Reversal of efflux of an anticancer drug in human drug-resistant breast cancer cells by inhibition of protein kinase Cα (PKCα) activity |
| Q36394925 | Science and technology of the emerging nanomedicines in cancer therapy: A primer for physicians and pharmacists |
| Q48292653 | Selection and optimization of nano-formulation of P-glycoprotein inhibitor for reversal of doxorubicin resistance in COLO205 cells |
| Q41382206 | Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment |
| Q35610203 | Stearoyl gemcitabine nanoparticles overcome resistance related to the over-expression of ribonucleotide reductase subunit M1. |
| Q47345264 | Surface Modification of Cisplatin-Complexed Gold Nanoparticles and Its Influence on Colloidal Stability, Drug Loading, and Drug Release. |
| Q34473472 | Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier |
| Q90411487 | The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target |
| Q42579919 | Transferrin-conjugated doxorubicin-loaded lipid-coated nanoparticles for the targeting and therapy of lung cancer |
| Q35978545 | Tumor penetrating peptides for improved drug delivery |
| Q39316251 | Vault nanoparticles engineered with the protein transduction domain, TAT48, enhances cellular uptake |
| Q38177770 | What nanomedicine in the clinic right now really forms nanoparticles? |
Search more.